Facebook
Twitter
Telegram
Report an ErrorStoke Therapeutics Financial Statements 2011-2024 | STOK
Annual Financial Statements Stoke Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
286 M | 349 M | 716 M | 2.03 B | 501 M | 36.3 B | - | - | - | - | - | - | - |
Shares |
44 M | 38.9 M | 36.7 M | 33.3 M | 18 M | 30.3 M | - | - | - | - | - | - | - |
Historical Prices |
6.5 | 8.97 | 19.5 | 59.9 | 24.8 | - | - | - | - | - | - | - | - |
Net Income |
-105 M | -101 M | -85.8 M | -52.2 M | -32.3 M | -12.5 M | -5.56 M | - | - | - | - | - | - |
Revenue |
8.78 M | 12.4 M | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-115 M | -104 M | -86.1 M | -53 M | -35.7 M | -12.8 M | - | - | - | - | - | - | - |
Interest Expense |
166 K | 167 K | 140 K | 101 K | 2 K | -10 K | - | - | - | - | - | - | - |
EBITDA |
-112 M | -103 M | -85.1 M | -52.2 M | -35.2 M | -12.6 M | -5.44 M | - | - | - | - | - | - |
Operating Expenses |
124 M | 117 M | 86.1 M | 53 M | 35.7 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
41.3 M | 38.9 M | 31.9 M | 20.8 M | 11.9 M | 4.41 M | 1.96 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Stoke Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
46.2 M | 45.9 M | 44.3 M | 44.2 M | 42.5 M | 39.4 M | 39.4 M | 39.3 M | 37.4 M | 36.9 M | 36.8 M | 36.7 M | 36.6 M | 36.6 M | 33.3 M | 33.1 M | 32.9 M | 32.9 M | 32.7 M | 5.08 M | 833 K | 727 K | 699 K | 691 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-26.4 M | - | -24.5 M | -30.7 M | -22.5 M | - | -26.1 M | -24.7 M | -24.6 M | - | -22.6 M | -22 M | -16.8 M | -14.6 M | -13.7 M | -13 M | -11 M | -10.2 M | -8.6 M | -7.82 M | -5.74 M | -4.28 M | -3.32 M | -3.01 M | -1.91 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
4.22 M | - | 3.31 M | -2.48 M | 5.15 M | - | 2.9 M | 3.23 M | 3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-28.4 M | - | -27.2 M | -33.3 M | -24.7 M | - | -27.1 M | -25.2 M | -24.8 M | - | -22.7 M | -22 M | -16.8 M | -14.6 M | -13.7 M | -13 M | -11.7 M | -11.1 M | -9.84 M | -8.44 M | -6.32 M | -4.54 M | -3.32 M | -3.01 M | -1.91 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
-428 K | - | 41 K | 41 K | 42 K | - | 42 K | 42 K | 42 K | - | 42 K | 28 K | 28 K | - | 28 K | 14 K | 22 K | - | 2 K | -3 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-27.8 M | - | - | - | -24.1 M | - | -26.2 M | -24.7 M | -24.5 M | - | -21.9 M | -21.5 M | -16.6 M | -14.6 M | -13.1 M | -12.6 M | -11.5 M | -11.1 M | -9.53 M | -8.26 M | -6.24 M | -4.54 M | -3.18 M | -2.94 M | -1.91 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
32.6 M | - | 30.5 M | 30.8 M | 29.8 M | - | 30.1 M | 28.5 M | 27.8 M | - | 22.7 M | 22 M | 16.8 M | 14.6 M | 13.7 M | 13 M | 11.7 M | 11.1 M | 9.84 M | 8.44 M | 6.32 M | 4.54 M | 3.32 M | 3.01 M | 1.91 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
10.2 M | - | 10.3 M | 10.2 M | 10.2 M | - | 9.94 M | 10.1 M | 9.49 M | - | 8.32 M | 7.93 M | 6.91 M | - | 5.6 M | 5.04 M | 4.52 M | - | 3.32 M | 2.42 M | 2.19 M | - | 1.09 M | 1.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency